$10.15
Live
0.0%
Downside
Day's Volatility :1.46%
Upside
1.46%
50.74%
Downside
52 Weeks Volatility :84.18%
Upside
67.88%
Period | American Well Corporation | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 18.85% | 3.6% | 0.0% |
6 Months | -6.39% | 10.2% | 0.0% |
1 Year | -49.31% | 19.6% | 0.0% |
3 Years | -94.12% | 16.8% | -23.0% |
Market Capitalization | 152.8M |
Book Value | $24.33 |
Earnings Per Share (EPS) | -21.08 |
Wall Street Target Price | 12.0 |
Profit Margin | -120.44% |
Operating Margin TTM | -83.42% |
Return On Assets TTM | -23.03% |
Return On Equity TTM | -60.92% |
Revenue TTM | 254.9M |
Revenue Per Share TTM | 17.53 |
Quarterly Revenue Growth YOY | 0.5% |
Gross Profit TTM | 116.8M |
EBITDA | -209.1M |
Diluted Eps TTM | -21.08 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -15.96 |
EPS Estimate Next Year | -8.69 |
EPS Estimate Current Quarter | -3.97 |
EPS Estimate Next Quarter | -3.78 |
What analysts predicted
Upside of 18.23%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 114.0M | - |
Net Income | -52.7M | - |
Net Profit Margin | -46.22% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 148.9M | ↑ 30.63% |
Net Income | -88.4M | ↑ 67.76% |
Net Profit Margin | -59.36% | ↓ 13.14% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 245.3M | ↑ 64.77% |
Net Income | -226.4M | ↑ 156.25% |
Net Profit Margin | -92.32% | ↓ 32.96% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 252.8M | ↑ 3.07% |
Net Income | -173.7M | ↓ 23.31% |
Net Profit Margin | -68.69% | ↑ 23.63% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 277.2M | ↑ 9.65% |
Net Income | -269.8M | ↑ 55.37% |
Net Profit Margin | -97.33% | ↓ 28.64% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 259.0M | ↓ 6.55% |
Net Income | -675.2M | ↑ 150.25% |
Net Profit Margin | -260.63% | ↓ 163.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 64.0M | ↓ 19.22% |
Net Income | -397.9M | ↑ 555.78% |
Net Profit Margin | -621.64% | ↓ 545.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 62.4M | ↓ 2.43% |
Net Income | -92.5M | ↓ 76.76% |
Net Profit Margin | -148.09% | ↑ 473.55% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 61.9M | ↓ 0.84% |
Net Income | -136.4M | ↑ 47.51% |
Net Profit Margin | -220.3% | ↓ 72.21% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 70.7M | ↑ 14.14% |
Net Income | -48.6M | ↓ 64.38% |
Net Profit Margin | -68.75% | ↑ 151.55% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 59.5M | ↓ 15.78% |
Net Income | -72.1M | ↑ 48.4% |
Net Profit Margin | -121.14% | ↓ 52.39% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 62.8M | ↑ 5.49% |
Net Income | -49.9M | ↓ 30.77% |
Net Profit Margin | -79.5% | ↑ 41.64% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 489.3M | - |
Total Liabilities | 693.7M | - |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 499.9M | ↑ 2.16% |
Total Liabilities | 780.7M | ↑ 12.54% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 175.39% |
Total Liabilities | 130.4M | ↓ 83.29% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 5.03% |
Total Liabilities | 185.0M | ↑ 41.79% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↓ 15.79% |
Total Liabilities | 133.7M | ↓ 27.71% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 589.7M | ↓ 51.57% |
Total Liabilities | 109.5M | ↓ 18.09% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 850.5M | ↓ 30.15% |
Total Liabilities | 136.2M | ↑ 1.89% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 772.2M | ↓ 9.21% |
Total Liabilities | 128.5M | ↓ 5.68% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 635.0M | ↓ 17.76% |
Total Liabilities | 115.3M | ↓ 10.26% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 589.7M | ↓ 7.13% |
Total Liabilities | 109.5M | ↓ 5.02% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 548.4M | ↓ 7.01% |
Total Liabilities | 125.0M | ↑ 14.16% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 507.8M | ↓ 7.4% |
Total Liabilities | 130.0M | ↑ 3.94% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -74.0M | - |
Investing Cash Flow | -245.9M | - |
Financing Cash Flow | 278.2M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -81.9M | ↑ 10.66% |
Investing Cash Flow | 120.0M | ↓ 148.79% |
Financing Cash Flow | 46.6M | ↓ 83.23% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -112.5M | ↑ 37.33% |
Investing Cash Flow | -66.8M | ↓ 155.63% |
Financing Cash Flow | 983.1M | ↑ 2007.93% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -141.5M | ↑ 25.85% |
Investing Cash Flow | -59.6M | ↓ 10.67% |
Financing Cash Flow | 5.8M | ↓ 99.41% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -192.3M | ↑ 35.88% |
Investing Cash Flow | -11.6M | ↓ 80.5% |
Financing Cash Flow | -3.6M | ↓ 162.77% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -29.1M | ↓ 18.91% |
Investing Cash Flow | -397.7M | ↓ 265.93% |
Financing Cash Flow | 1.6M | ↑ 273.14% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -39.6M | ↑ 35.95% |
Investing Cash Flow | 195.4M | ↓ 149.12% |
Financing Cash Flow | -305.0K | ↓ 119.6% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -38.0M | ↓ 4.13% |
Investing Cash Flow | 195.4M | ↑ 0.0% |
Financing Cash Flow | 896.0K | ↓ 393.77% |
Sell
Neutral
Buy
American Well Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
American Well Corporation | 1.87% | -6.39% | -49.31% | -94.12% | -97.76% |
Solventum Corp | 5.08% | 18.7% | 6.63% | 6.63% | 6.63% |
Tempus Ai | -10.87% | 22.58% | 22.58% | 22.58% | 22.58% |
Veeva Systems Inc. | 4.87% | 11.18% | 13.42% | -31.95% | 52.57% |
Ge Healthcare Technologies Inc. | 0.51% | 8.34% | 42.74% | 51.0% | 51.0% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
American Well Corporation | NA | NA | NA | -15.96 | -0.61 | -0.23 | NA | 24.33 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Tempus Ai | NA | NA | NA | -2.41 | 0.0 | 0.0 | NA | 0.64 |
Veeva Systems Inc. | 57.72 | 57.72 | 1.25 | 4.76 | 0.13 | 0.06 | NA | 32.04 |
Ge Healthcare Technologies Inc. | 26.25 | 26.25 | 2.37 | 4.25 | 0.21 | 0.06 | 0.0 | 17.08 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
American Well Corporation | Hold | $152.8M | -97.76% | NA | -120.44% |
Solventum Corp | Hold | $10.8B | 6.63% | NA | 15.73% |
Tempus Ai | NA | $7.9B | 22.58% | NA | -121.04% |
Veeva Systems Inc. | Buy | $35.1B | 52.57% | 57.72 | 23.91% |
Ge Healthcare Technologies Inc. | Buy | $41.7B | 51.0% | 26.25 | 8.1% |
Insights on American Well Corporation
Revenue is up for the last 2 quarters, 59.52M → 62.79M (in $), with an average increase of 5.2% per quarter
Netprofit is up for the last 2 quarters, -72.10M → -49.92M (in $), with an average increase of 44.4% per quarter
In the last 1 year, Ge Healthcare Technologies Inc. has given 42.6% return, outperforming this stock by 95.2%
RIMA MANAGEMENT, LLC
Morgan Stanley - Brokerage Accounts
Caledonia (Private) Investments Pty Ltd
Vanguard Group Inc
SATTER MANAGEMENT CO., L.P.
Renaissance Technologies Corp
amwell (previously known as american well) is a leading telehealth platform in the united states and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. amwell believes that digital care delivery will transform healthcare. the company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, behavioral health, as well as chronic care management and healthy living. with over a decade of experience, amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 80 million lives.
Organization | American Well Corporation |
Employees | 1104 |
CEO | Dr. Ido Schoenberg M.D. |
Industry | Technology Services |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$10.15
-1.84%
Invesco Bulletshares 2025 Hi
$10.15
-1.84%
Schwab International Dividend Equity Etf
$10.15
-1.84%
Blockchain Coinvestors Acquisition Corp.
$10.15
-1.84%
Allgiant Travel Company
$10.15
-1.84%
Rogers Corp
$10.15
-1.84%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$10.15
-1.84%
Iheartmedia
$10.15
-1.84%
Lightpath Technologies Inc
$10.15
-1.84%